NC Euphora™ NCEUP37520XRecalls & reported problems
Medtronic, Inc. · BALLOON NCEUP37520X NCEUPHORA RX US · Class 2
All models of NC Euphora (40)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169396265), received between Dec 2, 2025 and Dec 2, 2025 — classified as 1 malfunction.
The most frequently reported specific device problem is “Burst Container or Vessel” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Burst Container or Vessel1
- Deformation Due to Compressive Stress1
- Detachment of Device or Device Component1
- Inflation Problem1
- Positioning Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 2, 2025Burst Container or Vessel; Inflation Problem; Deformation Due to Compressive Stress; Detachment of Device or Device Component; Positioning Problem; Burst Container or Vessel; Inflation Problem; Deformation Due to Compressive Stress; Detachment of Device or Device Component; Positioning Problem
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING ONE NC EUPHORA RX BALLOON CATHETER, BALLOON INFLATION DIFFICULTIES WERE ENCOUNTERED AND THE BALLOON BURST DURING INFLATION. IT WAS ALSO REPORTED THAT IT WAS A STRUGGLE TO DELIVER THE BALLOON. A PRESSURE OF 12 ATM WAS APPLIED HOWEVER THE BALLOON FAILED TO REACH 12 ATM AS IT KEPT LOSING PRESSURE. THE BALLOON WAS NOT FULLY INFLATING. THE BALLOON RUPTURED AND THEY WERE VERY PRE-OCCUPIED WITH FLUSHING THE CATHETER. THE LESION BEING TREATED WAS NON TORTUOUS, HAD CHRONIC TOTAL OCCLUSION OF 100% AND WAS LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). THE DEVICE WAS INSPECTED PRIOR TO USE AND NEGATIVE PREP WAS PERFORMED WITH NO ISSUES NOTED. THE LESION WAS PRE-DILATED. THE DEVICE PASSED THROUGH A PREVIOUSLY-DEPLOYED STENT. RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE DEVICE AND EXCESSIVE FORCE WAS USED DURING DELIVERY. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23693031 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page